Department of Radiology, Massachusetts General Hospital, 55 Fruit St, WAC 240, Boston, MA 02114.
AJR Am J Roentgenol. 2024 Jun;222(6):e2430845. doi: 10.2214/AJR.24.30845. Epub 2024 Jun 5.
Radial scars are more commonly identified on digital breast tomosynthesis (DBT) than on digital mammography (DM). Nonetheless, universal guidelines for radial scar management in the current era of DBT are lacking. The purpose of this study was to determine the upstaging rates of screening DBT-detected radial scars with and without atypia and to identify features related to upstaging risk. This retrospective study included patients who underwent core needle biopsy (CNB) showing a radial scar after screening DBT and DM from January 1, 2013, to December 31, 2020. Patients without surgical excision or at least 2 years of imaging follow-up after CNB were excluded. Rates of upstaging to breast cancer (ductal carcinoma in situ [DCIS] or invasive disease) were compared between radial scars with and without atypia at CNB. Associations of upstaging with patient, imaging, and pathologic variables were explored using standard statistical tests. Of 165 women with 171 radial scars, the final study sample included 153 women (mean age, 56 years; range, 33-83 years) with 159 radial scars that underwent surgical excision (80.5%, 128/159) or at least 2 years of imaging follow-up (19.5%, 31/159). Seven radial scars were upstaged to DCIS and one to invasive disease. Therefore, the up-staging rate of radial scars to cancer was 5.0% (8/159). The upstaging rate of radial scars without atypia at CNB was 1.6% (2/129) and that of radial scars with atypia was 20.0% (6/30) ( < .001). On multivariable analysis, features associated with higher upstaging risk included a prior breast cancer diagnosis (62.5% vs 4.8%; = .01) and the presence of atypia at CNB (75.0% vs 15.9%; = .02). The upstaging rate according to mammographic finding type was 7.1% (1/14) for asymmetries, 12.5% (2/16) for masses, 5.3% (5/95) for architectural distortion, and 0.0% (0/34) for calcifications. Screening-detected radial scars without atypia at CNB have a low upstaging rate to breast cancer of 1.6%. Imaging surveillance rather than surgery is a reasonable approach for radial scars without atypia, particularly for those presenting as calcifications.
在数字乳腺断层摄影术(DBT)中比在数字乳腺摄影术(DM)中更常发现放射状瘢痕。尽管如此,在当前的 DBT 时代,缺乏放射状瘢痕管理的通用指南。本研究的目的是确定具有和不具有非典型性的筛查 DBT 检测到的放射状瘢痕的升级率,并确定与升级风险相关的特征。这项回顾性研究包括 2013 年 1 月 1 日至 2020 年 12 月 31 日期间因筛查 DBT 和 DM 后行核心针活检(CNB)显示放射状瘢痕而接受治疗的患者。排除了未行手术切除或 CNB 后至少 2 年影像学随访的患者。比较了 CNB 时具有和不具有非典型性的放射状瘢痕升级为乳腺癌(导管原位癌[DCIS]或浸润性疾病)的发生率。使用标准统计检验探讨了升级与患者、影像学和病理学变量的相关性。在 165 名患有 171 个放射状瘢痕的女性中,最终研究样本包括 153 名女性(平均年龄 56 岁;范围,33-83 岁),159 个放射状瘢痕行手术切除(80.5%,128/159)或至少 2 年影像学随访(19.5%,31/159)。7 个放射状瘢痕升级为 DCIS,1 个升级为浸润性疾病。因此,放射状瘢痕升级为癌症的发生率为 5.0%(8/159)。CNB 时无非典型性的放射状瘢痕的升级率为 1.6%(2/129),而具有非典型性的放射状瘢痕的升级率为 20.0%(6/30)(<.001)。多变量分析显示,与较高升级风险相关的特征包括既往乳腺癌诊断(62.5% vs 4.8%;=.01)和 CNB 时存在非典型性(75.0% vs 15.9%;=.02)。根据乳腺 X 线摄影发现类型,不对称的升级率为 7.1%(1/14),肿块的升级率为 12.5%(2/16),结构扭曲的升级率为 5.3%(5/95),钙化的升级率为 0.0%(0/34)。在 CNB 时无非典型性的筛查发现的放射状瘢痕中,乳腺癌的升级率为 1.6%,发生率较低。对于没有非典型性的放射状瘢痕,影像学监测而不是手术是一种合理的方法,特别是对于那些表现为钙化的放射状瘢痕。